Clinical trials
Phase 1 Alzheimer Disease trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
33 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Recruiting | 6 |
| Terminated | 6 |
| Active, not recruiting | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 6 |
| AstraZeneca | 4 |
| MODAG GmbH | 3 |
| Nxera Pharma UK Limited | 3 |
| Alnylam Pharmaceuticals | 2 |
| Denali Therapeutics Inc. | 2 |
| Eli Lilly and Company | 2 |
| Hoffmann-La Roche | 2 |
| Imperial College London | 2 |
| Alector Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alzheimer Disease | 33 |
| Neurodegenerative Diseases | 4 |
| Tauopathies | 4 |
| Cognitive Dysfunction | 3 |
| Multiple System Atrophy | 3 |
| Parkinson Disease | 3 |
| Dementia | 2 |
| Brain Diseases | 1 |
| Central Nervous System Diseases | 1 |
| Ketosis | 1 |
Trials
Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.